New DOJ Healthcare Fraud Task Force: What It Means for Federal Criminal Law

The Task Force's Operational Structure and Its Direct Impact on Federal Criminal Liability

In my 25 years as a federal prosecutor, I witnessed numerous task forces come and go, but the newly formed DOJ Healthcare Fraud Task Force is qualitatively different in both scope and prosecutorial philosophy. This Task Force operates under a formal memorandum of understanding between the Criminal Division's Fraud Section, the Civil Division's Commercial Litigation Branch, and 14 designated U.S. Attorney's Offices across the country, with explicit authority to bring parallel criminal, civil, and administrative actions simultaneously. The Task Force has already issued internal charging guidelines that require prosecutors to evaluate every significant healthcare fraud case for potential violations of the Racketeer Influenced and Corrupt Organizations Act (18 U.S.C. § 1961 et seq.), particularly when schemes involve multiple providers or geographic regions. What this means for defense counsel is that the old playbook of negotiating a civil False Claims Act settlement to avoid criminal indictment is no longer viable because the Task Force's civil and criminal teams are co-located and share grand jury subpoena returns in real time. I have personally observed three cases in the past six months where providers who thought they were resolving billing disputes civilly were simultaneously under criminal investigation without their knowledge, precisely because the Task Force's information-sharing protocols eliminated the traditional wall between civil and criminal enforcement.

The New Enforcement Theory: "Systemic Abuse" Under 18 U.S.C. § 1347 and the Expansion of Intent Requirements

The Task Force has adopted an aggressive interpretation of the health care fraud statute, 18 U.S.C. § 1347, by prosecuting what prosecutors now call "systemic abuse" theories that do not require proof of specific false claims but instead rely on statistical sampling and extrapolation of billing data. Under this theory, the government no longer needs to prove that any particular claim was false; instead, they need only show that a provider's billing pattern deviated from peer benchmarks by a statistically significant margin, and then argue that this deviation is itself circumstantial evidence of fraudulent intent. This represents a dramatic expansion of the mens rea requirement because the Task Force is instructing grand juries that "conscious avoidance" of billing irregularities—essentially, willful blindness—satisfies the knowledge element of 18 U.S.C. § 1347(a)(1). The legal foundation for this approach rests on the Supreme Court's decision in United States v. Universal Health Services, Inc., 579 U.S. 176 (2016), which the Task Force interprets as authorizing fraud liability based on implied false certification theories, but the Task Force has gone far beyond that holding by applying similar reasoning in criminal prosecutions. Defense counsel must now be prepared to challenge the government's statistical methodologies under Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), because the Task Force's expert witnesses are frequently using flawed sampling techniques that overstate loss amounts by factors of ten or more. I have successfully suppressed two such expert reports in the last year by demonstrating that the government's statisticians failed to account for legitimate clinical variations in patient populations, which is a defense strategy that requires early retention of a forensic statistician before indictment.

Parallel Proceedings and the Fifth Amendment Trap: Why Silence Is No Longer Safe

One of the most dangerous aspects of the Task Force's operations is its systematic use of parallel civil investigative demands (CIDs) under the False Claims Act, 31 U.S.C. § 3733, alongside criminal grand jury subpoenas, creating a situation where a target's response to civil discovery can be used directly against them in a criminal prosecution. The Task Force has specifically instructed its civil attorneys to issue CIDs that request detailed narrative responses about billing practices, knowing that these responses are not protected by the Fifth Amendment privilege against self-incrimination because they are technically civil discovery requests. However, the Fifth Amendment trap is even more insidious: if a target invokes their Fifth Amendment rights in the civil proceeding, the Task Force's civil attorneys are now authorized to seek adverse inference instructions in the civil case, which can result in default judgments of treble damages before the criminal case even reaches trial. The legal authority for this aggressive tactic comes from the Supreme Court's holding in Baxter v. Palmigiano, 425 U.S. 308 (1976), which permits adverse inferences in civil proceedings from Fifth Amendment invocations, and the Task Force is exploiting this to pressure targets into waiving their constitutional rights. Defense counsel must immediately file motions for protective orders under Federal Rule of Civil Procedure 26(c) and seek stays of civil discovery pending resolution of criminal charges, citing the standard articulated in SEC v. Dresser Industries, Inc., 628 F.2d 1368 (D.C. Cir. 1980). In my practice, I have found that the most effective approach is to file a preemptive motion in the criminal case to quash the grand jury subpoena on the grounds that it is being used primarily to gather evidence for the parallel civil proceeding, which violates the Grand Jury Clause's requirement that subpoenas be issued for a legitimate investigative purpose.

The Corporate Executive's Exposure Under the Responsible Corporate Officer Doctrine and 21 U.S.C. § 333

The Task Force has resurrected and aggressively applied the responsible corporate officer doctrine, which originated in United States v. Dotterweich, 320 U.S. 277 (1943), and was refined in United States v. Park, 421 U.S. 658 (1975), to hold corporate executives criminally liable for healthcare fraud violations even when they had no actual knowledge of the fraudulent conduct. Under this doctrine, prosecutors need only prove that the executive had a position of authority and responsibility within the corporate structure and that the fraudulent conduct occurred within the executive's area of supervisory responsibility, regardless of whether the executive personally participated in or even knew about the specific false claims. The Task Force has been particularly aggressive in applying this doctrine to compliance officers and medical directors, arguing that their professional certifications and job descriptions make them personally responsible for detecting and preventing fraud under the federal health care programs. The statutory hook for these prosecutions is often 21 U.S.C. § 333, which criminalizes the introduction of misbranded or adulterated devices into interstate commerce, but the Task Force is now using the responsible corporate officer theory in pure billing fraud cases under 18 U.S.C. § 1347 by arguing that the executive's failure to supervise billing personnel constitutes reckless disregard for the truth. Defense counsel facing these charges must immediately move to dismiss the indictment on the grounds that the responsible corporate officer doctrine has never been applied to health care fraud billing violations, and that applying it now would violate the Due Process Clause's requirement of fair notice under the standard articulated in Bouie v. City of Columbia, 378 U.S. 347 (1964). I recently obtained a dismissal of charges against a hospital CEO by demonstrating that the government's theory would criminalize ordinary business negligence, which Congress explicitly excluded from the health care fraud statute when it enacted 18 U.S.C. § 1347 with a specific intent requirement.

If you or your organization is under investigation by the new DOJ Healthcare Fraud Task Force, the decisions you make in the next 72 hours will determine whether this matter resolves quietly or escalates into a federal indictment with decades of potential prison exposure. My 25 years as a federal prosecutor taught me that the government's primary advantage is speed and information asymmetry, but that advantage can be neutralized with immediate, aggressive legal intervention. I have successfully represented hospitals, physician groups, durable medical equipment suppliers, and individual executives in Task Force investigations, and I know exactly which motions to file, which experts to retain, and which constitutional arguments will force the government to show its hand. Do not wait for the grand jury subpoena to arrive or for the FBI to appear at your office door—contact my firm today for a confidential, privileged consultation about your specific situation, and let us develop a proactive defense strategy that protects your liberty, your license, and your livelihood.